Mindfulness-based music therapy for patients undergoing stem cell transplantation
Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation
This study is testing a new music therapy program to see if it can help improve the well-being of patients going through stem cell transplants.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Miami Academic / other |
| Locations | 1 site (Miami, Florida) |
| Trial ID | NCT05968963 on ClinicalTrials.gov |
What this trial studies
This study aims to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) designed to enhance health-related quality of life and alleviate symptom burden in patients undergoing allogeneic stem cell transplantation. The intervention includes mindfulness-based music therapy and mindfulness meditation techniques. Participants will be assessed for their response to the intervention, focusing on improvements in their overall well-being during a challenging treatment process.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with specific blood cancers who are scheduled for an allogeneic stem cell transplant.
Not a fit: Patients with severe psychiatric illnesses, cognitive impairments, or those who have recently participated in similar therapies may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life for patients undergoing stem cell transplantation.
How similar studies have performed: Other studies have shown promising results with mindfulness and music therapy approaches in similar patient populations, suggesting potential for success in this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years of age * have a primary diagnosis of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or non Hodgkin's Lymphoma (NHL) * have a treatment plan for an allogeneic hematopoietic stem cell transplant * Speak English or Spanish Exclusion Criteria: * history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months) * severe cognitive impairment (per the short portable mental status questionnaire) * hearing impairment * active alcohol or substance dependence within the past six months * participated in music therapy or mindfulness programs in the past six months
Where this trial is running
Miami, Florida
- University of Miami — Miami, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Frank J. Penedo, PhD — University of Miami
- Study coordinator: Frank J Penedo, PhD
- Email: fpenedo@miami.edu
- Phone: (305) 284-4290
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.